Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 June 2024 | Story Edzani Nephalela | Photo Supplied
Dr Nomalungelo Ngubane
Dr Nomalungelo Ngubane, the Director of the Academy for Multilingualism, is at the forefront of this initiative, championing diversity and inclusiveness for all stakeholders at the University of the Free State.

Diversity in higher education institutions enriches the learning environment, fostering a culture of inclusion and mutual respect. It broadens perspectives, encourages critical thinking, and prepares students for a global workforce by supporting equitable access to opportunities and enhancing all students' personal growth and academic excellence.

The University of the Free State (UFS) has marked a significant milestone in its commitment to linguistic diversity with the official translation of its Language Policy into three additional languages: Sesotho, Afrikaans, and isiZulu. Previously only available in English, the translation of the policy – approved by the University Council in November 2023 – into these languages reflects the university's dedication to inclusivity and recognition of its diverse community.

The collaboration between the Academy for Multilingualism and the Institutional Regulatory Code was instrumental in a groundbreaking initiative: making the Language Policy accessible to speakers of African languages. Spearheaded by the Academy for Multilingualism, this endeavour involved a thorough translation, formatting, and proofreading process.

Dr Nomalungelo Ngubane, Director of the Academy for Multilingualism, emphasised that the availability of the Language Policy in multiple languages is not merely symbolic, but underscores the UFS' values of respect, human dignity, and social justice, as outlined in its Vision130. “This initiative aligns with the university's overarching goal of fostering an environment where all languages are valued and respected. We also hope that the Language Policy will not just be written in different languages but will strengthen the implementation of the policy in various domains of the university to achieve its objectives.

She further explains that the translation project is expected to have far-reaching impacts on how policies are communicated and understood within the university, because it enhances the ability of students, staff, and stakeholders to participate more fully in university life, contributing to a more cohesive and integrated community.

This initiative is a testament to the UFS' commitment to embracing and celebrating linguistic diversity as a fundamental aspect of its identity and operations.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept